The Vanguard Small-Cap Growth ETF, trading as VBK, reported an expense ratio of 0.07% and assets under management totaling $39.7 billion. In contrast, the Invesco S&P SmallCap 600 Pure Growth ETF, known as RZG, showed an expense ratio of 0.35% with $108.6 million in assets under management.
Performance data as of January 9, 2026, indicated a one-year total return of 15.9% for RZG, while VBK posted a 14.4% return. Both funds demonstrated nearly identical five-year maximum drawdowns, at -38.31% for RZG and -38.39% for VBK.
VBK currently holds 579 stocks, with significant exposure to technology at 27%, industrials at 21%, and healthcare at 18%. Its top holdings include Insmed Inc., Comfort Systems USA Inc., and SoFi Technologies Inc.
RZG maintains a portfolio of 131 stocks, emphasizing healthcare at 26%, industrials at 18%, and financial services at 16%. Its largest positions are ACM Research Inc., PTC Therapeutics Inc., and Progyny Inc.
The funds share a focus on U.S. small-cap growth stocks but employ distinct portfolio construction methods. VBK offers broader diversification and lower costs, while RZG provides a more concentrated approach with a recent performance edge.